(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Hostess Brands, VirTra, and Aurora Cannabis.

The three biggest losers today are SRAX, Sunworks, and VerifyMe.

Winners today

1. Hostess Brands (TWNKW) – 41.59%

Hostess Brands, Inc., a packaged food company, develops, manufactures, markets, sells, and distributes fresh sweet baked goods in the United States. It primarily offer a range of snack cakes, donuts, sweet rolls, breakfast pastries, snack pies, and related products. The company operates in two segments, Sweet Baked Goods and In-Store Bakery. The Sweet Baked Goods segment offers fresh and frozen sweet baked goods and bread products under the Hostess, Dolly Madison, Cloverhill, and Big Texas brands, as well as store branded products. The In-Store Bakery segment primarily provides Superior on Main branded eclairs, madeleines, brownies, and iced cookies in the bakery section of grocery and club stores. The company was formerly known as Gores Holdings, Inc. and changed its name to Hostess Brands, Inc. in November 2016. Hostess Brands, Inc. was founded in 1919 and is based in Lenexa, Kansas.

NASDAQ ended the session with Hostess Brands rising 41.59% to $3.20 on Tuesday while NASDAQ dropped 0.95% to $16,240.45.

PE Ratio

Hostess Brands has a trailing twelve months price to earnings ratio of 5.15. Meaning, the purchaser of the share is investing $5.15 for every dollar of annual earnings.

Yearly Top and Bottom Value

Hostess Brands’s stock is valued at $3.20 at 17:32 EST, way under its 52-week high of $4.02 and way higher than its 52-week low of $1.12.

More news about Hostess Brands.

2. VirTra (VTSI) – 33.44%

VirTra, Inc. provides force training simulators, firearms training simulators, and driving simulators for law enforcement, military, educational, and civilian worldwide. The company's products comprise V-300 simulator, a 300 degree wrap-around screen for simulation training; V-180 simulator, a 180 degree screen for smaller spaces or budgets; V-100, a single-screen based simulator system; V-100 MIL, a single-screen small arms training simulator; and V-ST PRO, a realistic single screen firearms shooting and skills training simulator. It also offers V-Author, a software that allows users to create, edit, and train with content specific to agency's objectives; Simulated Recoil Kits, a range of realistic and reliable simulated recoil kits/weapons; and Threat-Fire, a return fire device that applies real-world stress on the trainees during simulation training. In addition, the company provides VirTra Driving Sim, a vehicle-based simulator; Virtual Interactive Coursework Training Academy, which enables law enforcement agencies to each, train, test, and sustain departmental training requirements; Subscription Training Equipment Partnership, a program that allows agencies to utilize VirTra's simulator products, accessories, and V-VICTA interactive coursework on a subscription basis; and TASER, an OC spray and low-light training devices. It sells its simulators and related products through a direct sales force and distribution partners. The company was formerly known as VirTra Systems, Inc. and changed its name to VirTra, Inc. in October 2016. VirTra, Inc. was founded in 1993 and is based in Tempe, Arizona.

NASDAQ ended the session with VirTra jumping 33.44% to $12.73 on Tuesday while NASDAQ fell 0.95% to $16,240.45.

Earnings Per Share

As for profitability, VirTra has a trailing twelve months EPS of $0.64.

PE Ratio

VirTra has a trailing twelve months price to earnings ratio of 19.89. Meaning, the purchaser of the share is investing $19.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.47%.

More news about VirTra.

3. Aurora Cannabis (ACB) – 16.13%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

NYSE ended the session with Aurora Cannabis jumping 16.13% to $5.01 on Tuesday, after four successive sessions in a row of losses. NYSE slid 0.6% to $18,107.53, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-58.28.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.67%.

Yearly Top and Bottom Value

Aurora Cannabis’s stock is valued at $5.01 at 17:32 EST, way higher than its 52-week high of $1.21.

Volume

Today’s last reported volume for Aurora Cannabis is 14349100 which is 661% above its average volume of 1885550.

Moving Average

Aurora Cannabis’s value is way higher than its 50-day moving average of $0.47 and way above its 200-day moving average of $0.54.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 84.6% and 86.7%, respectively.

More news about Aurora Cannabis.

4. SCWorx Corp. (WORX) – 12.5%

SCWorx Corp. provides software solutions for the management of health care providers' foundational business applications in the United States. The company provides services related to repair, normalization, and interoperability of information, as well as big data analytics model that provides Web portal for display, and reporting and analysis of the information contained within the data warehouse. It also offers various software solutions and services, such as virtualized item master file repair, expansion, and automation; electronic medical record management, a module that integrates the advanced data attributes created in the item master to the electronic medical records; charge description master management(CDM), a module, which assists healthcare providers by integrating the CDM data into the workflow of the hospitals purchasing systems; contract management, a module that assists healthcare providers to establish a contract management system and to provide care to patients; request for proposal automation solution; rebate management; ScanWorx, a mobile perioperative closed loop scanning solution; and data integration and warehousing, as well as solutions for integration of acquired businesses, which enable deployment of a virtual item master files. The company sells its solutions and services to hospitals and health systems through its distribution and reseller partnerships. In addition, it provides CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling rapid test kits for COVID-19; and personal protective equipment. SCWorx Corp. is based in New York, New York.

NASDAQ ended the session with SCWorx Corp. jumping 12.5% to $3.78 on Tuesday while NASDAQ dropped 0.95% to $16,240.45.

Earnings Per Share

As for profitability, SCWorx Corp. has a trailing twelve months EPS of $-1.65.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.77%.

Volume

Today’s last reported volume for SCWorx Corp. is 361408 which is 84.15% below its average volume of 2280790.

Moving Average

SCWorx Corp.’s value is way higher than its 50-day moving average of $1.78 and way higher than its 200-day moving average of $2.77.

More news about SCWorx Corp..

5. Canopy Growth (CGC) – 10.89%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth rising 10.89% to $8.35 on Tuesday, after four sequential sessions in a row of losses. NASDAQ dropped 0.95% to $16,240.45, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-15.67.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.56%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Canopy Growth’s EBITDA is 1.8.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canopy Growth’s stock is considered to be overbought (>=80).

Volatility

Canopy Growth’s last week, last month’s, and last quarter’s current intraday variation average was 10.72%, 6.18%, and 6.50%.

Canopy Growth’s highest amplitude of average volatility was 21.38% (last week), 11.86% (last month), and 6.50% (last quarter).

Sales Growth

Canopy Growth’s sales growth is negative 17.2% for the current quarter and negative 17.7% for the next.

More news about Canopy Growth.

6. trivago N.V. (TRVG) – 9.42%

trivago N.V., together with its subsidiaries, operates a hotel and accommodation search platform in the United States, Germany, the United Kingdom, and internationally. It offers an online meta-search for hotels and accommodation through online travel agencies, hotel chains, and independent hotels. The company provides access to its platform through 53 localized websites and apps in 31 languages. As of December 31, 2021, its hotel search platform offered access to approximately 5.0 million hotels and other types of accommodation worldwide. The company was incorporated in 2005 and is headquartered in Düsseldorf, Germany. trivago N.V. is a subsidiary of Expedia Lodging Partner Services Sarl.

NASDAQ ended the session with trivago N.V. rising 9.42% to $3.02 on Tuesday while NASDAQ dropped 0.95% to $16,240.45.

Earnings Per Share

As for profitability, trivago N.V. has a trailing twelve months EPS of $-2.6.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.35%.

Moving Average

trivago N.V.’s worth is way above its 50-day moving average of $2.56 and way under its 200-day moving average of $4.20.

More news about trivago N.V..

7. Xenetic Biosciences (XBIO) – 8.66%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences jumping 8.66% to $4.39 on Tuesday, following the last session’s upward trend. NASDAQ fell 0.95% to $16,240.45, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-2.71.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.98%.

More news about Xenetic Biosciences.

8. Sabre Corporation (SABR) – 7.02%

Sabre Corporation, together with its subsidiaries, operates as software and technology company for travel industry in the United States, Europe, Asia-Pacific, and internationally. It operates through two segments: Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. Its Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.

NASDAQ ended the session with Sabre Corporation rising 7.02% to $2.59 on Tuesday, following the last session’s downward trend. NASDAQ fell 0.95% to $16,240.45, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Sabre Corporation has a trailing twelve months EPS of $-1.56.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.9%, now sitting on 2.91B for the twelve trailing months.

Volatility

Sabre Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.60%, a negative 0.52%, and a positive 3.72%.

Sabre Corporation’s highest amplitude of average volatility was 2.60% (last week), 3.79% (last month), and 3.72% (last quarter).

More news about Sabre Corporation.

9. Viomi Technology Co., Ltd (VIOT) – 6.81%

Viomi Technology Co., Ltd, through its subsidiaries, develops and sells Internet-of-things-enabled (IoT-enabled) smart home products in the People's Republic of China. The company offers IoT-enabled smart home products, including smart water purification systems; smart kitchen products, such as refrigerators, oven steamers, dishwashers, range hoods, and gas stoves; and other smart products comprising air conditioning systems, washing machines, water heaters, smart water kettles, sweeper robots, smart locks, and other smart devices. It also provides a suite of complementary consumable products; and value-added services. The company sells its products directly to consumers through its official Website, Viomi Store mobile app, and e-commerce channels, including Youpin, JD.com, Tmall, and Suning, as well as offline experience stores. It has a strategic partnership with Xiaomi Corporation. Viomi Technology Co., Ltd was founded in 2014 and is headquartered in Guangzhou, China.

NASDAQ ended the session with Viomi Technology Co., Ltd rising 6.81% to $0.59 on Tuesday, following the last session’s upward trend. NASDAQ fell 0.95% to $16,240.45, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Viomi Technology Co., Ltd has a trailing twelve months EPS of $-0.48.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.44%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 34.7%, now sitting on 2.49B for the twelve trailing months.

Moving Average

Viomi Technology Co., Ltd’s value is way under its 50-day moving average of $0.73 and way under its 200-day moving average of $0.87.

More news about Viomi Technology Co., Ltd.

10. Tiziana Life Sciences plc (TLSA) – 6.73%

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. The company was incorporated in 1998 and is headquatered in London, the United Kingdom.

NASDAQ ended the session with Tiziana Life Sciences plc jumping 6.73% to $0.46 on Tuesday while NASDAQ slid 0.95% to $16,240.45.

Earnings Per Share

As for profitability, Tiziana Life Sciences plc has a trailing twelve months EPS of $-0.18.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -90.4%.

Volume

Today’s last reported volume for Tiziana Life Sciences plc is 25336 which is 63.74% below its average volume of 69875.

Moving Average

Tiziana Life Sciences plc’s worth is under its 50-day moving average of $0.51 and way below its 200-day moving average of $0.62.

Yearly Top and Bottom Value

Tiziana Life Sciences plc’s stock is valued at $0.46 at 17:32 EST, way below its 52-week high of $1.39 and way above its 52-week low of $0.41.

More news about Tiziana Life Sciences plc.

Losers Today

1. SRAX (SRAX) – -78.95%

SRAX, Inc., a technology company, focused on enhancing communications between public companies and their shareholders and investors in the United States. The company offers Sequire, a Saas platform that allows issuers to track their shareholders' behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels. It also organizes and hosts investor conferences within the micro and small- cap space. The company markets and sells its services through its in-house sales and marketing team. The company was formerly known as Social Reality, Inc. and changed its name to SRAX, Inc. in August 2019. SRAX, Inc. was founded in 2009 and is headquartered in Westlake Village, California.

NASDAQ ended the session with SRAX falling 78.95% to $0.04 on Tuesday while NASDAQ dropped 0.95% to $16,240.45.

Earnings Per Share

As for profitability, SRAX has a trailing twelve months EPS of $-1.09.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -174.28%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 22.9%, now sitting on 28.27M for the twelve trailing months.

More news about SRAX.

2. Sunworks (SUNW) – -40.48%

Sunworks, Inc., through its subsidiaries, provides photovoltaic and battery based power and storage systems for the agricultural, commercial, industrial, public works, and residential markets in the United States. It also designs, finances, integrates, installs, and manages systems ranging in size from 2 kilowatt for residential projects to multi megawatt systems for larger commercial and public works projects. The company was formerly known as Solar3D, Inc. and changed its name to Sunworks, Inc. in March 2016. Sunworks, Inc. was incorporated in 2002 and is headquartered in Provo, Utah.

NASDAQ ended the session with Sunworks sliding 40.48% to $0.06 on Tuesday while NASDAQ dropped 0.95% to $16,240.45.

Earnings Per Share

As for profitability, Sunworks has a trailing twelve months EPS of $-1.63.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -135.47%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 30% and a negative 27.8%, respectively.

Volume

Today’s last reported volume for Sunworks is 31500900 which is 104.41% above its average volume of 15410000.

Revenue Growth

Year-on-year quarterly revenue growth declined by 29.5%, now sitting on 154.86M for the twelve trailing months.

Moving Average

Sunworks’s worth is way below its 50-day moving average of $0.18 and way under its 200-day moving average of $0.67.

More news about Sunworks.

3. VerifyMe (VRMEW) – -32.43%

VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, traceability, consumer engagement solutions, and authentication for labels, packaging, and products, as well as tamper-proof labels. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Lake Mary, Florida.

NASDAQ ended the session with VerifyMe falling 32.43% to $0.05 on Tuesday, after five sequential sessions in a row of losses. NASDAQ slid 0.95% to $16,240.45, following the last session’s upward trend on what was a somewhat down trend trading session today.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.96%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 10.2%, now sitting on 25.31M for the twelve trailing months.

More news about VerifyMe.

4. Verb Technology Company (VERBW) – -26.93%

Verb Technology Company, Inc. develops Software-as-a-Service applications platform. It offers verbLIVE, an interactive livestream eCommerce and shoppable video and webinar application; verbCRM, a white-labelled interactive video-based customer relationship management application; verbTEAMS, a self on-boarding version of verbCRM with built-in verbLIVE for small businesses and solo entrepreneurs; verbLEARN, an interactive video and gamified learning management system application; and verbMAIL, an interactive video mail solution integrated into Microsoft Outlook. The company provides non-digital services to enterprise clients, such as printing and fulfillment services. In addition, it offers subscription-based application services. The company serves large enterprises in the life sciences sector, professional sports franchises, and other business sectors. Verb Technology Company, Inc. was founded in 2012 and is based in Lehi, Utah.

NASDAQ ended the session with Verb Technology Company sliding 26.93% to $0.03 on Tuesday while NASDAQ dropped 0.95% to $16,240.45.

Earnings Per Share

As for profitability, Verb Technology Company has a trailing twelve months EPS of $-1.229.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -445.69%.

Yearly Top and Bottom Value

Verb Technology Company’s stock is valued at $0.03 at 17:32 EST, way under its 52-week high of $0.04 and way higher than its 52-week low of $0.02.

Revenue Growth

Year-on-year quarterly revenue growth grew by 866.7%, now sitting on 9.47M for the twelve trailing months.

More news about Verb Technology Company.

5. Humana (HUM) – -13.41%

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

NYSE ended the session with Humana dropping 13.41% to $304.33 on Tuesday while NYSE slid 0.6% to $18,107.53.

Earnings Per Share

As for profitability, Humana has a trailing twelve months EPS of $20.

PE Ratio

Humana has a trailing twelve months price to earnings ratio of 15.22. Meaning, the purchaser of the share is investing $15.22 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.68%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 34.3% and a negative 34%, respectively.

Previous days news about Humana

• Humana (hum) increases despite market slip: here's what you need to know. According to Zacks on Monday, 1 April, "In the context of valuation, Humana is at present trading with a Forward P/E ratio of 21.61. ", "For comparison, its industry has an average Forward P/E of 17.39, which means Humana is trading at a premium to the group."

More news about Humana.

6. Quidel (QDEL) – -10.32%

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

NASDAQ ended the session with Quidel sliding 10.32% to $42.15 on Tuesday while NASDAQ slid 0.95% to $16,240.45.

Earnings Per Share

As for profitability, Quidel has a trailing twelve months EPS of $-0.15.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.2%.

Sales Growth

Quidel’s sales growth is negative 9.5% for the ongoing quarter and 5.6% for the next.

More news about Quidel.

7. Marathon (MARA) – -8.78%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the bitcoin ecosystem in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon sliding 8.78% to $19.73 on Tuesday, following the last session’s downward trend. NASDAQ dropped 0.95% to $16,240.45, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $1.06.

PE Ratio

Marathon has a trailing twelve months price to earnings ratio of 18.61. Meaning, the purchaser of the share is investing $18.61 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.09%.

Volatility

Marathon’s last week, last month’s, and last quarter’s current intraday variation average was a positive 5.30%, a negative 0.70%, and a positive 6.46%.

Marathon’s highest amplitude of average volatility was 5.30% (last week), 5.51% (last month), and 6.46% (last quarter).

More news about Marathon.

8. Plug Power (PLUG) – -8.72%

Plug Power Inc. develops hydrogen and fuel cell product solutions in North America, Europe, Asia, and internationally. The company offers GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles; GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenKey, an integrated turn-key solution for transitioning to fuel cell power. It also provides electrolyzers, a hydrogen generator for clean hydrogen production; liquefaction systems that provides liquid hydrogen to customers; cryogenic equipment for the distribution of liquified hydrogen, oxygen, argon, nitrogen and other cryogenic gases, including trailers and mobile storage equipment; and liquid hydrogen, an alternative fuel to fossil-based energy. The company sells its products through a direct product sales force, original equipment manufacturers, and dealer networks. Plug Power Inc. was incorporated in 1997 and is headquartered in Latham, New York.

NASDAQ ended the session with Plug Power falling 8.72% to $3.14 on Tuesday, following the last session’s downward trend. NASDAQ dropped 0.95% to $16,240.45, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Plug Power has a trailing twelve months EPS of $-2.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.34%.

Moving Average

Plug Power’s worth is way below its 50-day moving average of $3.86 and way under its 200-day moving average of $6.90.

Volatility

Plug Power’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.41%, a negative 0.08%, and a positive 6.20%.

Plug Power’s highest amplitude of average volatility was 3.41% (last week), 4.34% (last month), and 6.20% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Plug Power’s stock is considered to be oversold (<=20).

More news about Plug Power.

9. FibroGen (FGEN) – -8.47%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen falling 8.47% to $2.16 on Tuesday, following the last session’s upward trend. NASDAQ fell 0.95% to $16,240.45, following the last session’s upward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-2.92.

Moving Average

FibroGen’s value is way higher than its 50-day moving average of $1.52 and way under its 200-day moving average of $3.01.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 49.4% and 55.6%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FibroGen’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for FibroGen is 894815 which is 66.12% below its average volume of 2641280.

More news about FibroGen.

10. Groupon (GRPN) – -8.34%

Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Groupon falling 8.34% to $11.65 on Tuesday while NASDAQ dropped 0.95% to $16,240.45.

Earnings Per Share

As for profitability, Groupon has a trailing twelve months EPS of $-1.77.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -567.07%.

More news about Groupon.

Stay up to date with our winners and losers daily report